Loading organization details...
Loading organization details...
Source: IRS e-Filed Form 990 (from the IRS e-File system), Tax Year 2024
Total Revenue
▼$109.1K
Program Spending
20%
of total expenses go to program services
Total Contributions
$52.5K
Total Expenses
▼$57.3K
Total Assets
$423.1K
Total Liabilities
▼$36.1K
Net Assets
$387.1K
Officer Compensation
→N/A
Other Salaries
N/A
Investment Income
$1,229
Fundraising
▼$24.5K
Source: USAspending.gov · Searched by organization name
Total Federal Funding
$3.7M
Awards Found
7
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Health and Human Services | LOW-COST FLEXIBLE SKIN-ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING | $2.3M | FY2014 | Aug 2014 – Oct 2017 |
| National Science Foundation | SBIR PHASE I: IN SITU VITRIFICATION TO UNLOCK ROUTINE ATOMIC-SCALE IMAGING OF BIOMOLECULE STRUCTURE AND CHEMISTRY IN THREE DIMENSIONS -THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROJECT INVESTIGATES FEASIBILITY OF A NEW MICROSCOPE SAMPLE VESSEL TECHNOLOGY TO PROVIDE THE WORLD?S FIRST ROUTINE CAPABILITY FOR IN SITU VITRIFICATION AND IMAGING (VITRIFICATION ON THE MICROSCOPE STAGE). EX SITU VITRIFICATION, SUCH AS PLUNGE FREEZING, IS A WELL-KNOWN BOTTLENECK TO THE SPEED AND QUALITY OF VITRIFIED SAMPLE STUDIES IN CRYO-ELECTRON MICROSCOPY (CRYO-EM), CRYO-X-RAY TOMOGRAPHY, AND ATOM PROBE TOMOGRAPHY (APT). COMPOUNDING THE PROBLEM, EX SITU VITRIFICATION EQUIPMENT IS INACCESSIBLE TO MOST RESEARCHERS DUE TO HIGH COSTS RANGING FROM TENS OF THOUSANDS TO MILLIONS OF DOLLARS. THE NEW SAMPLE VESSEL WILL BE FORMED IN A CONFINED AND READY-TO-IMAGE GEOMETRY, AVOIDING AIR-WATER INTERFACE DAMAGE AND ELIMINATING THE NEED FOR BLOTTING, MILLING, AND CUTTING. SUCCESSFUL DEVELOPMENT WILL MAKE EX SITU VITRIFICATION OBSOLETE FOR MANY APPLICATIONS, ENABLING A 100-FOLD REDUCTION IN COSTS AND A 20-FOLD IMPROVEMENT IN TIME-TO-DATA. COMBINED WITH APT, THE NEW SAMPLE VESSEL WILL PROVIDE THE FIRST ROUTINE CAPABILITY FOR IMAGING THE STRUCTURE AND CHEMISTRY OF BIOMOLECULES IN 3D. A BREAKTHROUGH THAT CAN BE USED STREAMLINE COMPUTER-AIDED DRUG DESIGN (CADD) BY PROVIDING DATA THAT CAN REDUCE PHARMACEUTICAL DEVELOPMENT COSTS BY UP TO HALF, A SAVINGS OF UP TO $1 BILLION PER DRUG. THE INTELLECTUAL MERIT OF THIS PROJECT RESIDES IN THE INNOVATIVE METHODS AND TRANSFORMATIVE POTENTIAL OF PROVING A NEW MICROSCOPE SAMPLE VESSEL TECHNOLOGY THAT CAN PHYSICALLY AND CHEMICALLY SUPPRESS ICE NUCLEATION IN ORDER TO PROVIDE ROUTINE IN SITU VITRIFICATION AND IMAGING. EX SITU VITRIFICATION, SUCH AS PLUNGE FREEZING, HAS HAD MAJOR SCIENTIFIC IMPACT, AS RECOGNIZED WITH THE 2017 NOBEL PRIZE. SUCCESSFUL IN SITU VITRIFICATION DEVELOPMENT WILL MAKE EX SITU VITRIFICATION OBSOLETE FOR MANY APPLICATIONS. IN PREVIOUS WORK, COMBINING THE NEW SAMPLE VESSEL WITH APT PERMITTED COLLECTING WORLD-FIRST THREE-DIMENSIONAL ATOM MAPS OF MONONUCLEOSOMES. PHOSPHOROUS ATOMS IN THE BACKBONE OF DNA WERE USED TO MEASURE THE DOUBLE-HELIX STRUCTURE WITH AN AVERAGE RESOLUTION OF 3.8 ?NGSTROMS. BROADER APPLICATION OF NEW SAMPLE VESSEL FACES TWO CHALLENGES: (1) LOW FILLING SUCCESS, FOR E.G., 20 DAYS TO IMAGE MONONUCLEOSOMES, AND (2) AN INABILITY TO ACHIEVE 1.5 ?NGSTROM RESOLUTION, A KEY TARGET FOR CADD. THIS PROJECT AIMS TO: (1) ACHIEVE 1 DAY TIME-TO-DATA BY EMPLOYING FRONT FILLING, GRAPHENE SEALING, AND FUNCTIONALIZING A SUPERHYDROPHILIC LUMEN; AND (2) ATTAIN 1.5 ?NGSTROM RESOLUTION USING A LASER MATCHING SCISSION ENERGY OF THE DOMINANT O-H BOND. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD. | $305K | FY2025 | Jun 2025 – May 2026 |
| Department of Health and Human Services | FLEXIBLE SKIN-ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING | $303.7K | FY2014 | Aug 2014 – Jul 2015 |
| Department of Health and Human Services | FLEXIBLE ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING IN CHILDREN | $270.7K | FY2014 | Aug 2014 – Jul 2015 |
| National Science Foundation | SBIR PHASE I: PROVIDING MICROSCOPY AT THE ULTIMATE RESOLUTION: POSITION, IDENTITY, OF EVERY ATOM, IN 3D | $225K | FY2017 | Dec 2016 – Feb 2018 |
| National Science Foundation | SBIR PHASE I: WEARABLE SLEEP MONITOR | $149.8K | FY2015 | Jan 2015 – Jun 2015 |
| Department of Agriculture | SEC. 9007 REAP-RENEW ENERGY SYS GRANTS (MAN) | $108.2K | FY2025 | Sep 2025 – Sep 2027 |
Department of Health and Human Services
$2.3M
LOW-COST FLEXIBLE SKIN-ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING
National Science Foundation
$305K
SBIR PHASE I: IN SITU VITRIFICATION TO UNLOCK ROUTINE ATOMIC-SCALE IMAGING OF BIOMOLECULE STRUCTURE AND CHEMISTRY IN THREE DIMENSIONS -THIS SMALL BUSINESS INNOVATION RESEARCH PHASE I PROJECT INVESTIGATES FEASIBILITY OF A NEW MICROSCOPE SAMPLE VESSEL TECHNOLOGY TO PROVIDE THE WORLD?S FIRST ROUTINE CAPABILITY FOR IN SITU VITRIFICATION AND IMAGING (VITRIFICATION ON THE MICROSCOPE STAGE). EX SITU VITRIFICATION, SUCH AS PLUNGE FREEZING, IS A WELL-KNOWN BOTTLENECK TO THE SPEED AND QUALITY OF VITRIFIED SAMPLE STUDIES IN CRYO-ELECTRON MICROSCOPY (CRYO-EM), CRYO-X-RAY TOMOGRAPHY, AND ATOM PROBE TOMOGRAPHY (APT). COMPOUNDING THE PROBLEM, EX SITU VITRIFICATION EQUIPMENT IS INACCESSIBLE TO MOST RESEARCHERS DUE TO HIGH COSTS RANGING FROM TENS OF THOUSANDS TO MILLIONS OF DOLLARS. THE NEW SAMPLE VESSEL WILL BE FORMED IN A CONFINED AND READY-TO-IMAGE GEOMETRY, AVOIDING AIR-WATER INTERFACE DAMAGE AND ELIMINATING THE NEED FOR BLOTTING, MILLING, AND CUTTING. SUCCESSFUL DEVELOPMENT WILL MAKE EX SITU VITRIFICATION OBSOLETE FOR MANY APPLICATIONS, ENABLING A 100-FOLD REDUCTION IN COSTS AND A 20-FOLD IMPROVEMENT IN TIME-TO-DATA. COMBINED WITH APT, THE NEW SAMPLE VESSEL WILL PROVIDE THE FIRST ROUTINE CAPABILITY FOR IMAGING THE STRUCTURE AND CHEMISTRY OF BIOMOLECULES IN 3D. A BREAKTHROUGH THAT CAN BE USED STREAMLINE COMPUTER-AIDED DRUG DESIGN (CADD) BY PROVIDING DATA THAT CAN REDUCE PHARMACEUTICAL DEVELOPMENT COSTS BY UP TO HALF, A SAVINGS OF UP TO $1 BILLION PER DRUG. THE INTELLECTUAL MERIT OF THIS PROJECT RESIDES IN THE INNOVATIVE METHODS AND TRANSFORMATIVE POTENTIAL OF PROVING A NEW MICROSCOPE SAMPLE VESSEL TECHNOLOGY THAT CAN PHYSICALLY AND CHEMICALLY SUPPRESS ICE NUCLEATION IN ORDER TO PROVIDE ROUTINE IN SITU VITRIFICATION AND IMAGING. EX SITU VITRIFICATION, SUCH AS PLUNGE FREEZING, HAS HAD MAJOR SCIENTIFIC IMPACT, AS RECOGNIZED WITH THE 2017 NOBEL PRIZE. SUCCESSFUL IN SITU VITRIFICATION DEVELOPMENT WILL MAKE EX SITU VITRIFICATION OBSOLETE FOR MANY APPLICATIONS. IN PREVIOUS WORK, COMBINING THE NEW SAMPLE VESSEL WITH APT PERMITTED COLLECTING WORLD-FIRST THREE-DIMENSIONAL ATOM MAPS OF MONONUCLEOSOMES. PHOSPHOROUS ATOMS IN THE BACKBONE OF DNA WERE USED TO MEASURE THE DOUBLE-HELIX STRUCTURE WITH AN AVERAGE RESOLUTION OF 3.8 ?NGSTROMS. BROADER APPLICATION OF NEW SAMPLE VESSEL FACES TWO CHALLENGES: (1) LOW FILLING SUCCESS, FOR E.G., 20 DAYS TO IMAGE MONONUCLEOSOMES, AND (2) AN INABILITY TO ACHIEVE 1.5 ?NGSTROM RESOLUTION, A KEY TARGET FOR CADD. THIS PROJECT AIMS TO: (1) ACHIEVE 1 DAY TIME-TO-DATA BY EMPLOYING FRONT FILLING, GRAPHENE SEALING, AND FUNCTIONALIZING A SUPERHYDROPHILIC LUMEN; AND (2) ATTAIN 1.5 ?NGSTROM RESOLUTION USING A LASER MATCHING SCISSION ENERGY OF THE DOMINANT O-H BOND. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Department of Health and Human Services
$303.7K
FLEXIBLE SKIN-ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING
Department of Health and Human Services
$270.7K
FLEXIBLE ADHESIVE PATCH FOR DIAGNOSING SLEEP DISORDERED BREATHING IN CHILDREN
National Science Foundation
$225K
SBIR PHASE I: PROVIDING MICROSCOPY AT THE ULTIMATE RESOLUTION: POSITION, IDENTITY, OF EVERY ATOM, IN 3D
National Science Foundation
$149.8K
SBIR PHASE I: WEARABLE SLEEP MONITOR
Department of Agriculture
$108.2K
SEC. 9007 REAP-RENEW ENERGY SYS GRANTS (MAN)
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Tax Year 2024 · Source: IRS e-Filed Form 990
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2024IRS e-File | $109.1K | $52.5K | $57.3K | $423.1K | $387.1K |
| 2023 | $66.6K | $9,618 | $51.5K | $381.6K | $339.4K |
| 2022 | $66.4K | $25.2K | $47.4K | $392.8K | $325.1K |
| 2021 | $69.4K | $32.5K |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990 | DataIRS e-File | |
| 2022 | 990 | DataIRS e-File |
Financial data: IRS e-Filed Form 990 (Tax Year 2024)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2024)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File
Tax-deductibility: IRS Publication 78
| Total |
|---|
| Maurice Cowan | 1st Vice President | 5 | $0 | $0 | $0 | $0 |
| Wayne M Leonard Jr | Treasurer | 5 | $0 | $0 | $0 | $0 |
| Terence Martin | President | 6 | $0 | $0 | $0 | $0 |
| Melvin Hodges | 2nd Vice President | 5 | $0 | $0 | $0 | $0 |
| Isaac Mckenzie | Secretary | 3 | $0 | $0 | $0 | $0 |
Maurice Cowan
1st Vice President
$0
Hrs/Wk
5
Compensation
$0
Related Orgs
$0
Other
$0
Wayne M Leonard Jr
Treasurer
$0
Hrs/Wk
5
Compensation
$0
Related Orgs
$0
Other
$0
Terence Martin
President
$0
Hrs/Wk
6
Compensation
$0
Related Orgs
$0
Other
$0
Melvin Hodges
2nd Vice President
$0
Hrs/Wk
5
Compensation
$0
Related Orgs
$0
Other
$0
Isaac Mckenzie
Secretary
$0
Hrs/Wk
3
Compensation
$0
Related Orgs
$0
Other
$0
Members of the governing board. Board members often serve without compensation.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Ernest Rentz | Director | 1 | $0 | $0 | $0 | $0 |
| Freeman Holifield | Director | 1 | $0 | $0 | $0 | $0 |
| Gerod Ferrell | Director | 1 | $0 | $0 | $0 | $0 |
| Houston Yarbrough | Director | 1 | $0 | $0 | $0 | $0 |
| Howard Tatum | Director | 1 | $0 | $0 | $0 | $0 |
| James Jennings | Director |
Ernest Rentz
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Freeman Holifield
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Gerod Ferrell
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
| $48.7K |
| $383.5K |
| $296.9K |
| 2020 | $32.7K | $13.7K | $45K | $357K | $276.2K |
| 2019 | $54.9K | $27.6K | $55.6K | $289.8K | $269.2K |
| 2018 | $95K | $58.9K | $69.6K | $305.8K | $264.7K |
| 2017 | $75K | $42.7K | $66.5K | $299.6K | $239.3K |
| 2016 | $64K | $29.8K | $57.9K | $311.2K | $230.8K |
| 2015 | $88K | $57.5K | $59.4K | $312.3K | $219.9K |
| 2014 | $53.4K | $28.8K | $59.6K | $302.4K | $191K |
| 2013 | $61.7K | $46K | $61.6K | $319.7K | $188.9K |
| 2012 | -$48.8K | $28.2K | $45.1K | $326.3K | $200.9K |
| 2011 | $33.6K | $34K | $36.9K | $420.7K | $212.4K |
| 2021 | 990 | Data | PDF not yet published by IRS |
| 2020 | 990 | Data |
| 2019 | 990 | Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990 | Data |
| 2014 | 990 | Data |
| 2013 | 990 | Data |
| 2012 | 990 | Data |
| 2011 | 990 | Data |
| 2010 | 990 | — |
| 2009 | 990 | — |
| 2008 | 990 | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2004 | 990 | — |
| 2003 | 990 | — |
| 2002 | 990 | — |
| 2001 | 990 | — |
| 1 |
| $0 |
| $0 |
| $0 |
| $0 |
| James Turnage | Director | 1 | $0 | $0 | $0 | $0 |
| Ralph Redrick | Director | 1 | $0 | $0 | $0 | $0 |
Houston Yarbrough
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Howard Tatum
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
James Jennings
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
James Turnage
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Ralph Redrick
Director
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0